| Eyecare Specialties | |
|
564 Valhi Blvd, Houma, LA 70360 | |
| (985) 876-6980 | |
| (985) 876-6975 |
| Full Name | Eyecare Specialties |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 564 Valhi Blvd, Houma, Louisiana |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588103469 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 1544-574AT (Louisiana) | Primary |
| 207W00000X | Ophthalmology | 011428 (Louisiana) | Secondary |
| Provider Name | Van M Ardoin |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1003991423 PECOS PAC ID: 9436226339 Enrollment ID: I20080918000262 |
News Archive
Genticel, a French biotechnology company and developer of innovative immunotherapies to prevent cancers caused by the human papillomavirus (HPV), announces today positive preclinical in vivo proof of concept results of GTL002, its multivalent HPV therapeutic vaccine candidate based on the Company's versatile Vaxiclase platform.
The work of a Kansas State University professor is challenging the assumption that genetically engineered plants are the great scientific and technological revolution in agriculture and the only efficient and cheap way to feed a growing population.
Oral and oropharyngeal cancer (cancer of the mouth and upper throat) collectively kill nearly one person every hour of every day of the year.
Regardless of where they are born in the United States, nearly all newborns now receive mandated screening for many life-threatening disorders, a remarkable public health advance of the last four years, according to a new report issued today by the March of Dimes.
› Verified 6 days ago
| Provider Name | Mark Joseph Ardoin |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1184891863 PECOS PAC ID: 6204903115 Enrollment ID: I20080918000301 |
News Archive
Genticel, a French biotechnology company and developer of innovative immunotherapies to prevent cancers caused by the human papillomavirus (HPV), announces today positive preclinical in vivo proof of concept results of GTL002, its multivalent HPV therapeutic vaccine candidate based on the Company's versatile Vaxiclase platform.
The work of a Kansas State University professor is challenging the assumption that genetically engineered plants are the great scientific and technological revolution in agriculture and the only efficient and cheap way to feed a growing population.
Oral and oropharyngeal cancer (cancer of the mouth and upper throat) collectively kill nearly one person every hour of every day of the year.
Regardless of where they are born in the United States, nearly all newborns now receive mandated screening for many life-threatening disorders, a remarkable public health advance of the last four years, according to a new report issued today by the March of Dimes.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eyecare Specialties 564 Valhi Blvd, Houma, LA 70360 Ph: (985) 876-6980 | Eyecare Specialties 564 Valhi Blvd, Houma, LA 70360 Ph: (985) 876-6980 |
News Archive
Genticel, a French biotechnology company and developer of innovative immunotherapies to prevent cancers caused by the human papillomavirus (HPV), announces today positive preclinical in vivo proof of concept results of GTL002, its multivalent HPV therapeutic vaccine candidate based on the Company's versatile Vaxiclase platform.
The work of a Kansas State University professor is challenging the assumption that genetically engineered plants are the great scientific and technological revolution in agriculture and the only efficient and cheap way to feed a growing population.
Oral and oropharyngeal cancer (cancer of the mouth and upper throat) collectively kill nearly one person every hour of every day of the year.
Regardless of where they are born in the United States, nearly all newborns now receive mandated screening for many life-threatening disorders, a remarkable public health advance of the last four years, according to a new report issued today by the March of Dimes.
› Verified 6 days ago
Shelley Huff, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 130 Enterprise Dr, Houma, LA 70360 Phone: 985-872-2020 | |
Nils Rege O.d., L.l.c. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1633 Martin Luther King Jr Blvd, Houma, LA 70360 Phone: 504-909-2800 | |
Dr. Otis J Bourg Jr., O. D. Optometrist Medicare: Medicare Enrolled Practice Location: 832 Belanger St, Houma, LA 70360 Phone: 985-872-1494 Fax: 985-580-4422 | |
Michelle F Sonnier, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 6008 W Main St, Houma, LA 70360 Phone: 985-872-3535 Fax: 985-879-3855 | |
Dr. Marc Roland Ardoin, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 603 Dunn St, Houma, LA 70360 Phone: 985-876-6980 Fax: 985-876-6975 | |
Dr. Nils Rege, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 933 Grand Caillou Rd, Houma, LA 70363 Phone: 504-909-2800 | |
Philip Rice, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5953 W Park Ave, 1031, Houma, LA 70364 Phone: 985-868-0699 Fax: 985-868-0535 |